Skip to main content
Log in

Effects of supplemental alpha-tocopherol and beta-carotene on urinary tract cancer: incidence and mortality in a controlled trial (Finland)

  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Objectives: Epidemiological studies have suggested a protective effect of vegetables and fruits on urinary tract cancer but the possible protective nutrients are unknown. We studied the effect of alpha-tocopherol (a form of vitamin E) and beta-carotene supplementation on urinary tract cancer in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study.

Methods: A total of 29,133 male smokers aged 50–69 years from southwestern Finland were randomly assigned to receive alpha-tocopherol (50 mg), beta-carotene (20 mg), both agents, or a placebo daily for 5–8 years (median 6.1 years). Incident urothelial cancers (bladder, ureter, and renal pelvis; n = 169) and renal cell cancers (n = 102) were identified through the nationwide cancer registry. The diagnoses were centrally confirmed by review of medical records and pathology specimens. The supplementation effects were estimated using a proportional hazards model.

Results: Neither alpha-tocopherol nor beta-carotene affected the incidence of urothelial cancer, relative risk 1.1 (95% confidence interval (CI) 0.8–1.5) and 1.0 (95% CI 0.7–1.3), respectively, or the incidence of renal cell cancer, relative risk 1.1 (95% CI 0.7–1.6) and 0.8 (95% CI 0.6–1.3), respectively.

Conclusion: Long-term supplementation with alpha-tocopherol and beta-carotene has no preventive effect on urinary tract cancers in middle-aged male smokers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. WHO (1997) The World Health Report. Geneva: World Health Organization.

    Google Scholar 

  2. Ross RK, Jones PA, Yu MC (1996) Bladder cancer epidemiology and pathogenesis. Semin Oncol 23: 536–545.

    PubMed  Google Scholar 

  3. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans (1986) Vol. 38: Tobacco Smoking. Lyon: IARC.

    Google Scholar 

  4. Motzer RJ, Bander NH, Nanus DM (1996) Renal-cell carcinoma. N Engl J Med 335: 865–875.

    Article  PubMed  Google Scholar 

  5. La Vecchia C, Negri E (1996) Nutrition and bladder cancer. Cancer Causes Control 7: 95–100.

    PubMed  Google Scholar 

  6. Wolk A, Lindblad P, Adami HO (1996) Nutrition and renal cell cancer. Cancer Causes Control 7: 5–18.

    PubMed  Google Scholar 

  7. Michaud DS, Spiegelman D, Clinton SK, Rimm EB, Willett WC, Giovannucci EL (1999) Fruit and vegetable intake and incidence of bladder cancer in a male prospective cohort. J Natl Cancer Inst 91: 605–613.

    PubMed  Google Scholar 

  8. The ATBC Cancer Prevention Study Group (1994) The Alpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study: design, methods, participant characteristics, and compliance. Ann Epidemiol 4: 1–10.

    Google Scholar 

  9. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group (1994) The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330: 1029–1035.

    Google Scholar 

  10. Pietinen P, Hartman AM, Haapa E, et al. (1988) Reproducibility and validity of dietary assessment instruments. I. A self-administered food use questionnaire with a portion size picture booklet. Am J Epidemiol 128: 655–666.

    PubMed  Google Scholar 

  11. Milne DB, Botnen J (1986) Retinol, alpha-tocopherol, lycopene, and alpha-and beta-carotene simultaneously determined in plasma by isocratic liquid chromatography. Clin Chem 32: 874–876.

    PubMed  Google Scholar 

  12. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, eds. (1992) American Joint Committee on Cancer. Manual for Staging of Cancer, 4th edn. Philadelphia: Lippincott.

    Google Scholar 

  13. Cox DR, Oakes D (1984) Analysis of Survival Data. London: Chapman & Hall.

    Google Scholar 

  14. Albanes D, Heinonen OP, Taylor PR, et al. (1996) α-Tocopherol and β-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 88: 1560–1570.

    PubMed  Google Scholar 

  15. Omenn GS, Goodman GE, Thornquist MD, et al. (1996) Risk factors for lung cancer and for intervention e.ects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 88: 1550–1559.

    PubMed  Google Scholar 

  16. Hennekens CH, Buring JE, Manson JE, et al. (1996) Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334: 1145–1149.

    PubMed  Google Scholar 

  17. Moon RC, Mehta RG, Rao KVN (1994) Retinoids and cancer in experimental animals. In: Sporn MB, Roberts AB, Goodman DS, eds. The Retinoids: Biology, Chemistry, and Medicine, 2nd edn. New York: Raven Press, pp. 573–595.

    Google Scholar 

  18. Alfthan O, Tarkkanen J, Gröhn P, Heinonen E, Pyrhönen S, Säilä K (1983) Tigason® (etretinate) in prevention of recurrence of superficial bladder tumors. Eur Urol 9: 6–9.

    PubMed  Google Scholar 

  19. Studer UE, Jenzer S, Biedermann C, et al. (1995) Adjuvant treatment with a vitamin A analogue (etretinate) after transurethral resection of superficial bladder tumors. Eur Urol 28: 284–290.

    PubMed  Google Scholar 

  20. Pedersen H, Wolf H, Kromann Jensen S, et al. (1984) Administration of a retinoid as prophylaxis of recurrent non-invasive bladder tumors. Scand J Urol Nephrol 18: 121–123.

    PubMed  Google Scholar 

  21. Messing EM, Vaillancourt A (1990) Hematuria screening for bladder cancer. J Occup Med 32: 838–845.

    PubMed  Google Scholar 

  22. Steiner M (1999) Vitamin E, a modifier of platelet function: rationale and use in cardiovascular and cerebrovascular disease. Nutr Rev 57: 306–309.

    PubMed  Google Scholar 

  23. Foresman WH, Messing EM (1997) Bladder cancer: natural history, tumor markers, and early detection strategies. Semin Surg Oncol 13: 299–306.

    PubMed  Google Scholar 

  24. Comstock GW, Bush TL, Helzlsouer K (1992) Serum retinol, beta-carotene, vitamin E, and selenium as related to subsequent cancer of specific sites. Am J Epidemiol 135: 115–121.

    PubMed  Google Scholar 

  25. Schoenberg JB, Stemhagen A, Mogielnicki AP, Altman R, Abe T, Mason TJ (1984) Case-control study of bladder cancer in New Jersey. I. Occupational exposures in white males. J Natl Cancer Inst 72: 973–981.

    PubMed  Google Scholar 

  26. Cohen SM (1998) Urinary bladder carcinogenesis. Toxicol Pathol 26: 121–127.

    PubMed  Google Scholar 

  27. World Cancer Research Fund in association with American Institute for Cancer Research (1997) Food, Nutrition and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research, pp. 330–337.

    Google Scholar 

  28. Wolk A, Gridley G, Niwa S, et al. (1996) International renal cell cancer study. VII. Role of diet. Int J Cancer 65: 67–73.

    PubMed  Google Scholar 

  29. Tavani A, Pregnolato A, Violante A, La Vecchia C, Negri E (1997) Attributable risks for kidney cancer in Northern Italy. Eur J Cancer Prev 6: 195–199.

    PubMed  Google Scholar 

  30. Yuan JM, Gago-Dominguez M, Castelao JE, Hankin JH, Ross RK, Yu MC (1998) Cruciferous vegetables in relation to renal cell carcinoma. Int J Cancer 77: 211–216.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Virtamo, J., Edwards, B.K., Virtanen, M. et al. Effects of supplemental alpha-tocopherol and beta-carotene on urinary tract cancer: incidence and mortality in a controlled trial (Finland). Cancer Causes Control 11, 933–939 (2000). https://doi.org/10.1023/A:1026546803917

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026546803917

Navigation